Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
MMA-0874
Approved small_molecule completed
Quick answer
Harvoni (Fixed dose combination ledipasvir/sofosbuvir) for Hepatitis C is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Hepatitis C
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed